YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Publicly traded biotech firm expands to STL

Posted online

San Francisco-based immunology company Vir Biotechnology Inc. (Nasdaq: VIR) is expanding to St. Louis.

The biotechnology firm is opening an office and innovation lab in space previously occupied by Washington University.

Vir has several drug candidates for infectious diseases, including COVID-19.

Read more from the St. Louis Business Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences